Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus.

The association of insulin-dependent diabetes mellitus (IDDM) with certain HLA alleles is well documented in pediatric patients. Whether a similar association is found in adult-on-set IDDM is not clear, although the disease occurs after the age of 20 in 50% of cases. HLA class II DRB1, DQA1, and DQB1 alleles were studied in 402 type I diabetics and 405 healthy controls (all Caucasian) using oligonucleotide typing after gene amplification. Alleles DRB1*03, DRB1*04, DQB1*0201, DQB1*0302, DQA1*0301, and DQA1*0501 were indeed enriched in diabetics and the highest relative risk was observed in patients carrying both the DRB1*03-DQB1*0201 and the DRB1*0402 or DRB1*0405-DQB1*0302 haplotypes. However none of these alleles, or specific residues, could alone account for the susceptibility to IDDM. Furthermore, there were major differences in HLA class II gene profiles according to the age of onset. Patients with onset after 15 yr (n = 290) showed a significantly higher percentage of non-DR3/non-DR4 genotypes than those with childhood onset (n = 112) and a lower percentage of DR3/4 genotypes. These non-DR3/non-DR4 patients, although presenting clinically as IDDM type 1 patients, showed a lower frequency of islet cell antibodies at diagnosis and a significantly milder initial insulin deficiency. These subjects probably represent a particular subset of IDDM patients in whom frequency increases with age. The data confirm the genetic heterogeneity of IDDM and call for caution in extrapolating to adult patients the genetic concepts derived from childhood IDDM.

[1]  William,et al.  POLYMORPHIC DQa AND DQf8 INTERACTIONS DICTATE HLA CLASS II DETERMINANTS OF ALLO-RECOGNITION , 2003 .

[2]  R B Smith,et al.  Insulin dependent diabetes mellitus. , 1992, The New Zealand medical journal.

[3]  P. Bedossa,et al.  Identification and mapping to chromosome 1 of a susceptibility locus for periinsulitis in non-obese diabetic mice , 1991, Nature.

[4]  G. Nepom,et al.  Allelic polymorphism in transcriptional regulatory regions of HLA-DQB genes , 1991, The Journal of experimental medicine.

[5]  H. Erlich,et al.  MHC class-II molecules and autoimmunity. , 1991, Annual review of immunology.

[6]  D. Charron.  Molecular Basis of Human Leukocyte Antigen Class II , 1990, Advances in Immunology.

[7]  C. Boitard,et al.  Plasma C-Peptide Levels and Clinical Remissions in Recent-Onset Type I Diabetic Patients Treated With Cyclosporin A and Insulin , 1990, Diabetes.

[8]  F. Christiansen,et al.  Supratypes and ancestral haplotypes in IDDM: potential importance of central non-HLA MHC genes. , 1990, Journal of autoimmunity.

[9]  G. Nepom,et al.  HLA-DQ and Diabetes Mellitus: A Genetic and Structural Paradigm for Models of Disease Susceptibility , 1990 .

[10]  E. Thorsby,et al.  The amino acid at position 57 of the HLA-DQ beta chain and susceptibility to develop insulin-dependent diabetes mellitus. , 1989, Human immunology.

[11]  J. Todd,et al.  Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping , 1989, Nature.

[12]  J. Ilonen,et al.  A comparison of childhood and adult type I diabetes mellitus. , 1989, The New England journal of medicine.

[13]  M. Baur,et al.  Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. , 1988, American journal of human genetics.

[14]  J. Todd,et al.  Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Dausset,et al.  HLA-DQ rather than HLA-DR region might be involved in dominant nonsusceptibility to diabetes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[16]  H. Erlich,et al.  Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Cathelineau,et al.  Pattern of Treatment Among Diabetic Patients in France , 1988, Diabetes Care.

[18]  J. R. Rowe,et al.  T-cell-defined DR4 subtypes as markers for type 1 diabetes. , 1988, Human Immunology.

[19]  B. Michelsen,et al.  Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ. , 1987, The Journal of clinical investigation.

[20]  N. Maclaren,et al.  Maturity-onset diabetes of youth in black Americans. , 1987, The New England journal of medicine.

[21]  F. Bach,et al.  DR2+ haplotypes in insulin-dependent diabetes: analysis of DNA restriction fragment length polymorphisms. , 1986, Human immunology.

[22]  S. Holbeck,et al.  Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis , 1986, The Journal of experimental medicine.

[23]  N. Arnheim,et al.  Use of pooled DNA samples to detect linkage disequilibrium of polymorphic restriction fragments and human disease: studies of the HLA class II loci. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Elliott,et al.  IMPROVED SENSITIVITY OF ISLET CELL CYTOPLASMIC ANTIBODY ASSAY IN DIABETICS , 1984, The Lancet.

[25]  G. Eisenbarth,et al.  Type I diabetes mellitus: a chronic autoimmune disease? , 1984, Pediatric clinics of North America.

[26]  J. Dausset,et al.  Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[27]  P. A. Peterson,et al.  HLA-D region β-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals , 1983, Nature.

[28]  L. Melton,et al.  Incidence of Diabetes Mellitus by Clinical Type , 1983, Diabetes Care.

[29]  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. , 1979, Diabetes.

[30]  D. R. Gamble,et al.  ISLET-CELL ANTIBODIES IN DIABETES MELLITUS , 1976, The Lancet.